CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics

BACKGROUND: This research aimed at exploring the mechanisms of alterations of metabolites and pathways in T2D from the perspective of metabolomics and transcriptomics, as well as uncovering novel drug candidate for T2D treatment. METHODS: Metabolites in human plasma from 42 T2D patients and 45 non‐d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cell Mol Med
Hoofdauteurs: Li, Hailong, Shi, Xiaodong, Jiang, Hua, Kang, Junren, Yu, Miao, Li, Qifei, Yu, Kang, Chen, Zhengju, Pan, Hui, Chen, Wei
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7339182/
https://ncbi.nlm.nih.gov/pubmed/32469143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15357
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items